1. Home
  2. VLYPO vs VCEL Comparison

VLYPO vs VCEL Comparison

Compare VLYPO & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Valley National Bancorp 5.50% Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock Series B

VLYPO

Valley National Bancorp 5.50% Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock Series B

N/A

Current Price

$25.11

Market Cap

0.0

Sector

Finance

ML Signal

N/A

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$37.86

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VLYPO
VCEL
Founded
N/A
1989
Country
United States
United States
Employees
3732
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
2.0B
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
VLYPO
VCEL
Price
$25.11
$37.86
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$57.50
AVG Volume (30 Days)
N/A
599.1K
Earning Date
N/A
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
236.54
EPS
N/A
0.25
Revenue
N/A
$258,716,999.00
Revenue This Year
N/A
$17.86
Revenue Next Year
N/A
$18.55
P/E Ratio
N/A
$152.71
Revenue Growth
N/A
14.05
52 Week Low
N/A
$29.24
52 Week High
N/A
$63.00

Technical Indicators

Market Signals
Indicator
VLYPO
VCEL
Relative Strength Index (RSI) 47.32 51.36
Support Level $24.80 $35.53
Resistance Level $25.31 $38.09
Average True Range (ATR) 0.18 1.35
MACD -0.03 0.05
Stochastic Oscillator 39.24 71.10

Price Performance

Historical Comparison
VLYPO
VCEL

About VLYPO Valley National Bancorp 5.50% Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock Series B

Valley National Bancorp is a bank holding company that offers a full suite of national and regional banking solutions through various commercial, private banking, retail, insurance, and wealth management financial services products. It provides personalized service and customized solutions to assist its customers with their financial service needs. The group also offers niche financial services, including loan and deposit products for homeowners associations, cannabis-related business banking, and venture banking, which offers nationally. It manages its business operations under operating segments consisting of Consumer Banking; Commercial Banking; and Treasury and Corporate Other. The group generates the majority of its revenue from the Commercial Banking Segment.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: